Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE3.1800
- TODAY'S CHANGE (%)0.1600 (5.2980%)
- Bid / Lots3.0400/ 1
- Ask / Lots3.3000/ 5
- Open / Previous Close3.0500 / 3.0200
- Day Range
- 52 Week Range
- Volume300,254
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 100 | 3.065 |
| 09:34 ET | 300 | 3.05 |
| 09:36 ET | 100 | 3.06 |
| 09:38 ET | 300 | 3.09 |
| 09:41 ET | 1400 | 3.12 |
| 09:43 ET | 700 | 3.13 |
| 09:45 ET | 100 | 3.14 |
| 09:48 ET | 400 | 3.14 |
| 09:50 ET | 100 | 3.14 |
| 09:52 ET | 200 | 3.14 |
| 09:54 ET | 1100 | 3.13 |
| 09:56 ET | 3614 | 3.11 |
| 10:01 ET | 800 | 3.12 |
| 10:03 ET | 200 | 3.12 |
| 10:06 ET | 100 | 3.12 |
| 10:08 ET | 600 | 3.11 |
| 10:10 ET | 100 | 3.13 |
| 10:12 ET | 400 | 3.13 |
| 10:14 ET | 300 | 3.13 |
| 10:15 ET | 400 | 3.13 |
| 10:17 ET | 2980 | 3.14 |
| 10:19 ET | 15307 | 3.17 |
| 10:21 ET | 3644 | 3.16 |
| 10:24 ET | 1200 | 3.16 |
| 10:26 ET | 600 | 3.17 |
| 10:30 ET | 400 | 3.17 |
| 10:32 ET | 811 | 3.18 |
| 10:33 ET | 200 | 3.19 |
| 10:35 ET | 605 | 3.19 |
| 10:37 ET | 400 | 3.19 |
| 10:39 ET | 300 | 3.19 |
| 10:42 ET | 357 | 3.21 |
| 10:44 ET | 300 | 3.21 |
| 10:46 ET | 1902 | 3.19 |
| 10:48 ET | 100 | 3.185 |
| 10:50 ET | 2599 | 3.165 |
| 10:51 ET | 177 | 3.165 |
| 11:00 ET | 100 | 3.18 |
| 11:02 ET | 399 | 3.18 |
| 11:04 ET | 100 | 3.18 |
| 11:06 ET | 684 | 3.18 |
| 11:08 ET | 550 | 3.18 |
| 11:09 ET | 7534 | 3.12 |
| 11:11 ET | 300 | 3.13 |
| 11:13 ET | 300 | 3.14 |
| 11:15 ET | 4868 | 3.11 |
| 11:18 ET | 200 | 3.115 |
| 11:20 ET | 1290 | 3.08 |
| 11:22 ET | 100 | 3.09 |
| 11:26 ET | 28169 | 3.1019 |
| 11:27 ET | 3524 | 3.105 |
| 11:31 ET | 199 | 3.112 |
| 11:33 ET | 100 | 3.105 |
| 11:36 ET | 649 | 3.12 |
| 11:38 ET | 700 | 3.12 |
| 11:40 ET | 4769 | 3.09 |
| 11:42 ET | 100 | 3.095 |
| 11:44 ET | 100 | 3.095 |
| 11:45 ET | 100 | 3.095 |
| 11:49 ET | 980 | 3.11 |
| 11:51 ET | 650 | 3.12 |
| 11:54 ET | 500 | 3.12 |
| 11:56 ET | 300 | 3.11 |
| 11:58 ET | 300 | 3.12 |
| 12:00 ET | 1299 | 3.1 |
| 12:02 ET | 500 | 3.1 |
| 12:03 ET | 200 | 3.1 |
| 12:05 ET | 100 | 3.1 |
| 12:07 ET | 1100 | 3.085 |
| 12:09 ET | 200 | 3.085 |
| 12:12 ET | 100 | 3.085 |
| 12:14 ET | 100 | 3.07 |
| 12:16 ET | 300 | 3.08 |
| 12:18 ET | 1429 | 3.08 |
| 12:20 ET | 100 | 3.08 |
| 12:21 ET | 100 | 3.08 |
| 12:23 ET | 918 | 3.07 |
| 12:25 ET | 351 | 3.0634 |
| 12:27 ET | 300 | 3.09 |
| 12:36 ET | 300 | 3.1 |
| 12:38 ET | 200 | 3.1 |
| 12:39 ET | 450 | 3.1 |
| 12:43 ET | 650 | 3.095 |
| 12:45 ET | 20180 | 3.13 |
| 12:48 ET | 14392 | 3.1195 |
| 12:54 ET | 1200 | 3.13 |
| 12:56 ET | 900 | 3.13 |
| 12:57 ET | 500 | 3.13 |
| 12:59 ET | 300 | 3.13 |
| 01:01 ET | 300 | 3.14 |
| 01:03 ET | 1100 | 3.16 |
| 01:06 ET | 300 | 3.16 |
| 01:08 ET | 300 | 3.16 |
| 01:10 ET | 3600 | 3.13 |
| 01:12 ET | 100 | 3.13 |
| 01:14 ET | 400 | 3.13 |
| 01:19 ET | 500 | 3.15 |
| 01:21 ET | 100 | 3.15 |
| 01:24 ET | 2403 | 3.13 |
| 01:26 ET | 100 | 3.14 |
| 01:28 ET | 200 | 3.13 |
| 01:32 ET | 100 | 3.135 |
| 01:33 ET | 600 | 3.14 |
| 01:37 ET | 780 | 3.14 |
| 01:39 ET | 100 | 3.15 |
| 01:42 ET | 607 | 3.14 |
| 01:44 ET | 100 | 3.15 |
| 01:46 ET | 200 | 3.15 |
| 01:48 ET | 100 | 3.15 |
| 01:50 ET | 100 | 3.15 |
| 01:51 ET | 400 | 3.15 |
| 01:53 ET | 100 | 3.15 |
| 01:55 ET | 300 | 3.14 |
| 01:57 ET | 400 | 3.15 |
| 02:00 ET | 2033 | 3.15 |
| 02:02 ET | 334 | 3.18 |
| 02:04 ET | 200 | 3.18 |
| 02:06 ET | 200 | 3.18 |
| 02:08 ET | 3433 | 3.175 |
| 02:09 ET | 1310 | 3.16 |
| 02:13 ET | 500 | 3.17 |
| 02:20 ET | 100 | 3.18 |
| 02:22 ET | 700 | 3.1741 |
| 02:24 ET | 700 | 3.19 |
| 02:26 ET | 1100 | 3.19 |
| 02:27 ET | 200 | 3.2 |
| 02:29 ET | 2174 | 3.19 |
| 02:31 ET | 100 | 3.18 |
| 02:33 ET | 213 | 3.19 |
| 02:40 ET | 2257 | 3.17 |
| 02:42 ET | 120 | 3.1693 |
| 02:44 ET | 100 | 3.18 |
| 02:51 ET | 801 | 3.18 |
| 02:54 ET | 574 | 3.18 |
| 02:58 ET | 300 | 3.18 |
| 03:00 ET | 100 | 3.19 |
| 03:02 ET | 300 | 3.19 |
| 03:03 ET | 400 | 3.18 |
| 03:05 ET | 2469 | 3.17 |
| 03:07 ET | 400 | 3.16 |
| 03:09 ET | 200 | 3.16 |
| 03:12 ET | 400 | 3.17 |
| 03:14 ET | 390 | 3.17 |
| 03:16 ET | 1355 | 3.155 |
| 03:20 ET | 695 | 3.16 |
| 03:21 ET | 200 | 3.16 |
| 03:23 ET | 400 | 3.155 |
| 03:25 ET | 444 | 3.16 |
| 03:27 ET | 1093 | 3.17 |
| 03:30 ET | 646 | 3.18 |
| 03:32 ET | 100 | 3.17 |
| 03:34 ET | 200 | 3.18 |
| 03:36 ET | 400 | 3.18 |
| 03:38 ET | 300 | 3.18 |
| 03:39 ET | 1165 | 3.17 |
| 03:41 ET | 3493 | 3.16 |
| 03:43 ET | 300 | 3.175 |
| 03:45 ET | 483 | 3.175 |
| 03:50 ET | 500 | 3.175 |
| 03:52 ET | 1909 | 3.18 |
| 03:54 ET | 2657 | 3.2 |
| 03:56 ET | 4174 | 3.2 |
| 03:57 ET | 6850 | 3.19 |
| 03:59 ET | 5714 | 3.18 |
May 29, 2024
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences, from 4:36PM ET on Wednesday May 29, 2024 by Dow Jones
4:36PM ET on Wednesday May 29, 2024 by Dow Jones
May 15, 2024
*DJ Kodiak Sciences 1Q Loss/Shr 82c >KOD, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow JonesKodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow Jones
May 13, 2024
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy, from 7:32PM ET on Monday May 13, 2024 by Dow Jones
7:32PM ET on Monday May 13, 2024 by Dow Jones
May 2, 2024
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform, from 4:30PM ET on Thursday May 02, 2024 by Dow Jones
4:30PM ET on Thursday May 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 158.7M | -0.7x | --- |
Atossa Therapeutics Inc | 163.5M | -5.5x | --- |
X4 Pharmaceuticals Inc | 163.9M | -1.4x | --- |
Rezolute Inc | 166.6M | -3.5x | --- |
Context Therapeutics Inc | 150.0M | -1.5x | --- |
Outlook Therapeutics Inc | 169.0M | -0.6x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $167.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.42 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
